Companies like Pfizer, Lilly Icos and Bayer who make Viagra, Cialis and Levitra respectively have welcomed news from the FDA in the United States regarding new proposals for the regulation of the advertising of their erectile dysfunction medicines.

Under the new proposals the drug companies will pay a bigger fee to the FDA each year for their licences but at the same time they will have a far better system for dealing with the FDA that will hopefully mean and end to them getting warning letters, having to suddenly change advert campaigns and being forced off the air.
The proposals will soon be put to the United States congress and mainly concern the use of television adverts for these drugs that have been the issue of much controversy in recent years.

The FDA proposal asks for an increase of 29% yearly paid by the pharmaceutical companies which would go towards a system by which the approval times for any new medicines and drugs would be speeded up and as well as that the FDA would commit themselves to a special pre-review television advertisements for all prescription medicines.

The FDA proposal asks for an increase of 29% yearly paid by the pharmaceutical companies which would go towards a system by which the approval times for any new medicines and drugs would be speeded up and as well as that the FDA would commit themselves to a special pre-review television advertisements for all prescription medicines.

The advantage of this would mean that the adverts would all have FDA approval before the get released rather than them having to be pulled after the ad campaigns had started thus costing the drug companies millions in lost revenue and redrafting of the adverts.

The initiative for the move however seems to have some from the drug industry who had previously suggested and come up with a private writing with the FDA to review all adverts before they were shown so that costly time delays before the airing of the impotence and other adverts could be avoided. The fees that are likely to be generated in extra revenue by the FDA are in the region of 400 million dollars and would fund a whole department to review the TV adverts.

The companies that make erectile dysfunction drugs are to be especially positive about the idea as so many of their adverts were felt to have stepped over the boundaries of what is permitted with regard to the advertising of prescription medication. Ukmedix will be following up with more on this story as updates come in and will keep you posted.